Ortho Clinical Diagnostics
The Company maintains a leadership position in two major market segments:
Donor Screening - Development and commercialization of instrument systems and reagents that screen blood for AIDS, hepatitis and Chagas Disease, aimed at ensuring the safety of the world's blood supply. Immunohematology - Ortho Clinical Diagnostics is the worldwide leader in the marketing and development of instrumentation and reagent systems that enable blood typing, aimed at ensuring patient-donor compatibility in blood transfusions.
Clinical Chemistry - Patented dry-slide technology and systems for use in stat and random access in-vitro diagnostic testing. The company offers a broad menu covering basic metabolites, classical chemistries, special chemistries, proteins, toxicology and therapeutic drug monitoring tests.
Immunodiagnostics - Enhanced Chemiluminescence technology and systems offering Immunoassay testing capabilities across many categories of thyroid function, reproductive endocrinology, cardiology, anemia, metabolism, oncology and infectious diseases.
Today, we’re focused on creating innovative new diagnostic products, improving existing ones, advancing your knowledge and shaping the future of diagnostics within global health care. Our work is all about changing lives.